The present invention provides a method of treating behavioral disorders such as attention deficit hyperactivity disorder, comprising administering an effective amount of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine or a pharmaceutically acceptable salt thereof to a patient in need thereof and the like.

 
Web www.patentalert.com

< Cysteine Protease Inhibitors

> SUBSTITUTED QUINAZOLINES AS PDE10 INHIBITORS

~ 00491